Clinical Trial 43642

Morrow, GA 30260


Summary:

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis.


Qualified Participants Must:

• Demonstrated an inadequate response, loss of response, or intolerance to at least one of the following treatments including:

-oral aminosalicylates

-corticosteroids

-immunosuppressants

-biologic therapies


Qualified Participants May Receive:

Free Medication

Free Treatment

Compensation for time and travel

 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.